United States · FDA National Drug Code directory
Tobradex ST
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71776-035_2bd6e870-446a-02f4-e063-6394a90a27b0
- Product NDC
- 71776-035
- Form
- SUSPENSION/ DROPS
- Composition / generic term
- tobramycin / dexamethasone
- Labeler
- Eyevance Pharmaceuticals, LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20210519
- Source listing expiry
- 20261231
Source-listed ingredients
- TOBRAMYCIN — 3 mg/mL
- DEXAMETHASONE — .5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, DROPPER in 1 CARTON (71776-035-01) / 1 mL in 1 BOTTLE, DROPPER · 71776-035-01
- 1 BOTTLE, DROPPER in 1 CARTON (71776-035-05) / 5 mL in 1 BOTTLE, DROPPER · 71776-035-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →